Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Diagnosis of peripartum depression disorder: A state-of-the-art approach from the COST Action Riseup-PPD Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

June 13, 2025

  • Women’s Health
    Women’s Health

    Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.

  • Postpartum Depression (PPD)
    Postpartum Depression (PPD)

    Postpartum depression (PPD) affects many new mothers, influencing emotional, mental, and physical well-being. The gut microbiome, hormones, diet, and exercise all play a significant role in the onset, severity, and management of PPD. Early intervention, including probiotics, dietary changes, and therapy, can effectively alleviate symptoms and improve maternal and child health outcomes.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-06-12

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was reviewed?

The review synthesizes the latest research comparing peripartum depression (PPD) with major depressive disorder (MDD), emphasizing diagnostic criteria, prevalence, symptom profiles, developmental trajectory, and comorbidities. The researchers particularly focused on delineating PPD as a potentially distinct entity rather than merely a subtype or specifier of MDD. They reviewed evidence regarding clinical characteristics, diagnostic features, symptom presentation, cultural considerations, and associated risk factors. The review further explored risk factors unique to PPD, such as ovarian tissue expression differences, premenstrual syndrome, unintended pregnancies, and specific obstetric complications.

Who was reviewed?

This review synthesizes research literature rather than studying individual subjects. It includes studies from various databases covering pregnant and postpartum women diagnosed or at risk of peripartum depression (PPD), comparing these findings against major depressive disorder (MDD) populations in general. Special attention was given to differences across cultural settings, indicating a significant variation in prevalence and symptom manifestation.

What were the most important findings?

The review identified critical distinctions between PPD and general MDD. PPD exhibits less typical depressive symptoms such as profound sadness and suicidal thoughts, while significantly heightened symptoms include anxiety, irritability, obsessive intrusive thoughts about harming the infant, psychomotor agitation, and decision-making difficulties. Additionally, the onset of PPD is broader than current diagnostic criteria suggest, commonly starting anytime during pregnancy and potentially extending throughout the first postpartum year. Furthermore, there are distinct risk factors, notably related to hormonal fluctuations and obstetric complications, which differ markedly from general depression risk factors. Cultural variance significantly influences the prevalence and expression of PPD symptoms, necessitating culturally sensitive diagnostic approaches. The review underscored that clinicians need to consider PPD as potentially requiring distinct diagnostic criteria rather than merely a subset of MDD, emphasizing the importance of tailored diagnostic tools and criteria specific to the peripartum context.

What are the greatest implications of this review?

The greatest implication of this review is advocating for revising and broadening diagnostic criteria for PPD, emphasizing the inclusion of anxiety and specific maternal-related symptoms. Extending the onset specifier throughout pregnancy and the entire postpartum year could significantly improve accurate diagnosis and intervention. Highlighting the unique characteristics of PPD could encourage tailored treatments, reduce stigma, and improve maternal and child health outcomes by ensuring better recognition, diagnosis, and management of this disorder.

Postpartum Depression (PPD)

Postpartum depression (PPD) affects many new mothers, influencing emotional, mental, and physical well-being. The gut microbiome, hormones, diet, and exercise all play a significant role in the onset, severity, and management of PPD. Early intervention, including probiotics, dietary changes, and therapy, can effectively alleviate symptoms and improve maternal and child health outcomes.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.